Recrutamento encerrado
FASE
Número Europeu 2021-000678-27
ASC4FIRST
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
Detalhes
Destaques